Acuta Capital Partners’s LeonaBio Inc LONA Stock Holding History

Acuta Capital Partners’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$1.35M	–	45
2022 Q1	$1.35M	Buy	+10,000	New	+$1.05M	0.63%	32

Other funds holding LONA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acuta Capital Partners's LONA Position: Q2 2022 in Review

Acuta Capital Partners sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 14,003 shares — an estimated $1.89M sold.

Acuta Capital Partners first reported a position in LONA in Q3 2020 and held it in 7 quarters. The position peaked at $13.5M in Q4 2020. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

Acuta Capital Partners reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
Acuta Capital Partners sold 14,003 LeonaBio Inc shares in Q2 2022, an estimated $1.89M.
Acuta Capital Partners first reported a position in LeonaBio Inc in Q3 2020 and held it in 7 quarters.
Acuta Capital Partners's LeonaBio Inc position peaked at $13.5M in Q4 2020.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Acuta Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.